SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.05 |
| Enterprise Value ($M) | 0.71 |
| Book Value ($M) | 2.86 |
| Book Value / Share | 0.87 |
| Price / Book | 1.07 |
| NCAV ($M) | 0.72 |
| NCAV / Share | 0.22 |
| Price / NCAV | 4.26 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.32 |
| Return on Assets (ROA) | -0.95 |
| Return on Equity (ROE) | -1.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.44 |
| Current Ratio | 1.44 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.56 |
| Assets | 4.70 |
| Liabilities | 1.84 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -10.11 |
| Net Income | -9.83 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -8.35 |
| Cash from Investing | 7.77 |
| Cash from Financing | 0.11 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 17,985 | 124,132 | 14.49 | |
| 39,019 | 187,440 | 20.82 | |
| 72,537 | 380,773 | 19.05 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APM – Aptorum Group Limited | APRE – Aprea Therapeutics, Inc. |
| APVO – Aptevo Therapeutics Inc. | ASNS – Actelis Networks, Inc. |
| ASRT – Assertio Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io